These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11480390)

  • 21. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
    Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
    J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B; Caffier H; Sütterlin MW; Dietl J
    Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
    Alatalo SL; Peng Z; Janckila AJ; Kaija H; Vihko P; Vaananen HK; Halleen JM
    J Bone Miner Res; 2003 Jan; 18(1):134-9. PubMed ID: 12510815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
    Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
    J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)].
    Mochizuki Y
    Clin Calcium; 2006 Jun; 16(6):948-55. PubMed ID: 16751690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of bone turnover after a short period of steroid therapy in elderly men.
    Paglia F; Dionisi S; De Geronimo S; Rosso R; Romagnoli E; Raejntroph N; Ragno A; Celi M; Pepe J; D'Erasmo E; Minisola S
    Clin Chem; 2001; 47(7):1314-6. PubMed ID: 11427468
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of biomarkers in diagnosis of metabolic bone diseases].
    Suzuki Y
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2151-8. PubMed ID: 18044149
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between sex hormone fluctuations and biomarkers of bone resorption in bovine plasma during the oestrous cycle.
    Devkota B; Itagaki K; Kim D; Sasaki K; Osawa T; Furuhama K; Yamagishi N
    Vet J; 2012 Nov; 194(2):256-8. PubMed ID: 22578633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
    Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE
    Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma fluctuation in estradiol-17β and bone resorption markers around parturition in dairy cows.
    Devkota B; Takahashi M; Sato S; Sasaki K; Ueki A; Osawa T; Takahashi M; Yamagishi N
    J Vet Med Sci; 2015 Jul; 77(7):875-8. PubMed ID: 25755022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    Avbersek-Luznik I; Balon BP; Rus I; Marc J
    Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
    Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK
    Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S; Menzel C; Kurth AA; Obert K; Breidert I; Borowsky K; Böttcher HD
    Anticancer Res; 2003; 23(3C):2783-8. PubMed ID: 12926113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
    Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
    Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
    J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
    J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.